SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-29
👔
Roivant Sciences Ltd.
@ROIV_InsiderForm 4 Filing: Sukhatme Mayukh Sells $38.0M of $ROIV
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Roivant Sciences Ltd.
Ticker: $ROIV
Transaction Value
$38.0M
Price/Share: $18.98
transaction date
2026-06-25
Shares: 2,000,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Sukhatme Mayukh, holds the title of President & CIO at Roivant Sciences Ltd..
On 2026-06-25, the insider transacted 2,000,000 shares.The shares were transacted at a weighted average price of $18.98 per share, resulting in a total market-relevant value of $38.0M.
Executive Summary Summary
Sukhatme Mayukh (President & CIO) sold $38.0M of $ROIV
Post-Transaction Position: 18,677,617 shares
SEC Accession No: 0001635088-26-000073 (CIK: 1750050)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.